Platinum Investment Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-55,341	Closed	-$1.63M	–	149
2023 Q2	$1.63M	Hold	55,341	–	–	0.06%	86
2023 Q1	$1.28M	Hold	55,341	–	–	0.04%	95
2022 Q4	$1.54M	Buy	55,341 +4,370	+9%	+$130K	0.06%	90
2022 Q3	$1.56M	Hold	50,971	–	–	0.07%	85
2022 Q2	$1.5M	Hold	50,971	–	–	0.06%	94
2022 Q1	$1.64M	Hold	50,971	–	–	0.05%	90
2021 Q4	$2.27M	Buy	50,971 +20,180	+66%	+$956K	0.06%	92
2021 Q3	$1.55M	Hold	30,791	–	–	0.04%	109
2021 Q2	$2.42M	Hold	30,791	–	–	0.06%	87
2021 Q1	$1.76M	Hold	30,791	–	–	0.04%	93
2020 Q4	$2.58M	Sell	30,791 -40,002	-57%	-$2.42M	0.06%	80
2020 Q3	$2.54M	Hold	70,793	–	–	0.06%	71
2020 Q2	$1.71M	Hold	70,793	–	–	0.04%	92
2020 Q1	$1.24M	Buy	+70,793	New	+$1.48M	0.03%	93